[Federal Register Volume 68, Number 74 (Thursday, April 17, 2003)]
[Notices]
[Page 18972]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-9469]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Ebola Virion Proteins 
Expressed From Venezuelan Equine Encephalitis (VEE) Virus Replicons

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6 and 404.7, announcement is 
made of the availability for licensing of U.S. Patent Application No. 
09/337,946 entitled ``Ebola Virion Proteins Expressed from Venezuelan 
Equine Encephalitis (VEE) Virus Replicons,'' filed June 22, 1999. 
Foreign rights are also available (PCT/US99/14311). The United States 
Government, as represented by the Secretary of the Army, has rights in 
this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: Using the Ebola GP, NP, VP24, VP30, VP35 and 
VP40 virion proteins, a method and composition for use in inducing an 
immune response which is protective against infection with Ebola virus 
is described.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 03-9469 Filed 4-16-03; 8:45 am]
BILLING CODE 3710-08-M